Sort
23,748 grants matching “melanoma”
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
$398,204Guangyong Peng · Saint Louis University · R01 · FY2022 · CA
NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases
$398,197Yolonda L Colson · Brigham And Women'S Hospital · R01 · FY2008 · CA
Epigenetic enhancer control in maintaining homeostasis and preventing carcinogenesis in the epidermis
$398,067Brian Capell · University Of Pennsylvania · R01 · FY2023 · AR
Endothelial plasticity in glioma vascularization and therapy resistance
$398,055Yi Fan · University Of Pennsylvania · R01 · FY2021 · NS
Development of first-in-class antagonists of the retinoid pathway as novel oral immunotherapies for solid cancers
$398,040Mark Esposito · Kayothera Inc. · R43 · FY2023 · CA
Therapeutic resistance and tumor heterogeneity in BRAF mutant colorectal cancer
$398,025Ryan Bruce Corcoran · Massachusetts General Hospital · R01 · FY2016 · CA
Therapeutic resistance and tumor heterogeneity in BRAF mutant colorectal cancer
$398,025Ryan Bruce Corcoran · Massachusetts General Hospital · R01 · FY2017 · CA
Experimental Transformation of Human Melanocytes in Vivo
$398,003Meenhard Herlyn · Wistar Institute · R01 · FY2006 · CA
Vaccine strategies for HIVAIDS
$397,966Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
$397,908John H Sampson · Duke University · R01 · FY2017 · NS
DNA Repair, Skin Cancer and Overall Cancer Risk
$397,869Anthony J Alberg · Medical University Of South Carolina · R01 · FY2008 · CA
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses
$397,814John M. Wrangle · Medical University Of South Carolina · R01 · FY2021 · CA
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses
$397,814Mark P Rubinstein · Medical University Of South Carolina · R01 · FY2020 · CA
Cell lineage and transcriptional analysis of the vertebrate neural plate border
$397,813Marianne Bronner-Fraser · California Institute Of Technology · R01 · FY2020 · DE
Clonal analysis of the cranial neural crest
$397,813Marianne Bronner-Fraser · California Institute Of Technology · R01 · FY2019 · DE
Local Immuroregulation of Cutaneous Carcinogenesis
$397,813Michael Girardi · Yale University · R01 · FY2017 · CA
Local Immuroregulation of Cutaneous Carcinogenesis
$397,813Michael Girardi · Yale University · R01 · FY2018 · CA
Local Immuroregulation of Cutaneous Carcinogenesis
$397,813Michael Girardi · Yale University · R01 · FY2020 · CA
Novel Methods for Identifying Genetic Interactions for Cancer Prognosis
$397,813Shuangge Ma · Yale University · R01 · FY2021 · CA
Cell lineage and transcriptional analysis of the vertebrate neural plate border
$397,813Marianne Bronner-Fraser · California Institute Of Technology · R01 · FY2019 · DE
Methods for profiling the cancer virome and microbial strain genetics
$397,771Curtis Huttenhower · Broad Institute, Inc. · R21 · FY2025 · CA
Regulation of stem-like CD8+ T cells and their role in immunotherapy
$397,630Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2023 · CA
MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
$397,626Mobile Infirmary Medical Center · U10 · FY2001 · CA
Production and use of Pb-203 for cancer therapy research
$397,597Herbert A Moore · Alphamed, Inc · R44 · FY2008 · CA
Project 3: Integrative Computational Analysis of Tumor-Mediated Immunosuppression
$397,549Sylvia Katina Plevritis · Stanford University · U54 · FY2020 · CA